Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5

Xu Zhang1, Yuan Zhuang1, Tian Qin1

  • 1The Key Laboratory of Rare Metabolic Diseases, The Key Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing 211166, China.

Insights

Suppressor of cytokine signaling-2 (SOCS2) regulates hepatic gluconeogenesis and glucose homeostasis. Metformin increases SOCS2, which inhibits glucose production, suggesting SOCS2 as a potential diabetes therapeutic target.

Area of Science:

  • Endocrinology
  • Metabolism
  • Molecular Biology

Background:

  • Hepatic gluconeogenesis is vital for blood glucose homeostasis.
  • Suppressor of cytokine signaling-2 (SOCS2) is a cytokine signaling inhibitor.
  • SOCS2 knockout mice resist high-fat diet-induced metabolic dysfunction, but its role in glucose metabolism is unclear.

Purpose of the Study:

  • To elucidate the mechanism by which SOCS2 regulates hepatic glucose homeostasis.
  • To investigate the role of SOCS2 in metformin's glucose-lowering effects.

Main Methods:

  • Studied SOCS2 expression in fasted and metformin-treated mice (C57BL/6J, db/db).
  • Utilized gain- and loss-of-function studies in hepatocytes and db/db mice.
  • Investigated the JAK2/STAT5 signaling pathway and SOCS2-JAK2-STAT5 interactions.

Main Results:

  • Hepatic SOCS2 expression decreased in fasted and db/db mice, but increased with metformin.
  • SOCS2 deficiency impaired metformin's ability to suppress gluconeogenesis.
  • SOCS2 regulates gluconeogenic gene expression and glucose output via JAK2/STAT5.
  • SOCS2 inactivates STAT5 by disrupting the JAK2-STAT5 interaction, reducing gluconeogenesis.

Conclusions:

  • SOCS2 plays a critical role in regulating hepatic gluconeogenesis.
  • Metformin's inhibition of gluconeogenesis is partly mediated by SOCS2 upregulation.
  • SOCS2 represents a potential therapeutic target for diabetes treatment.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
5.3K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.8K